Clinical Trials on Solar Skin Damage in China

Total 3962 results

Aimin Dang

Recruiting

China Takayasu Arteritis Registry (CTA Registry)

TAKAYASU ARTERITIS

China
Longbio Pharma

Active, not recruiting

A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants

Chronic Spontaneous Urticaria

China
Shanghai BDgene Co., Ltd.
Eye & ENT Hospital of Fudan University

Completed

Safety and Efficacy of CRISPR/Cas9 mRNA Instantaneous Gene Editing Therapy to Treat Refractory Viral Keratitis

Cornea | Herpes Simplex Virus Infection | Viral Keratitis | Blindness Eye

China
OrienGene Biotechnology Ltd.

Unknown

A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c

Melanoma

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Clinical Trial of Microneedle Radiofrequency Combined With Oral Isotretinoin in Moderate to Severe Acne

Moderate to Severe Acne Vulgaris

China
Peking Union Medical College Hospital

Recruiting

The Choice of Treatment Methods and Efficacy of LABC

Locally Advanced Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Chinese Academy of Medical Sciences Cancer Hospital，Shanxi Center; Chinese... and other collaborators

Not yet recruiting

Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer

Breast Cancer | Neoadjuvant Therapy

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Mindfulness Yoga and Sexual Functioning

Breast Cancer | Sexual Dysfunction

China
The Hong Kong Polytechnic University
Ruijin Hospital

Recruiting

The Effects of a Nurse-led mHealth Program for Symptom Self-management of Breast Cancer Patients Undergoing Chemotherapy (mChemo)

Breast Cancer | Chemotherapeutic Toxicity

China
Suzhou Kintor Pharmaceutical Inc,

Completed

To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects

Alopecia | Acne

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Breast Neoplasms

China
Pierre Fabre Dermo Cosmetique

Completed

IN-USE TOLERANCE STUDY UNDER DERMATOLOGICAL AND OPHTHALMOLOGICAL CONTROLS AND EFFICACY ASSESSMENT (Face Balm)

Hypersensitive | Reactive and Intolerant Skin | Redness-prone Skin | Stinger Subjects

China
Second Affiliated Hospital of Soochow University

Recruiting

A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC

Breast Neoplasms

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Breast Neoplasms

China
Shengjing Hospital

Recruiting

Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients

Breast Neoplasms

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Completed

Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction

Breast Neoplasms

China
Shanghai Dermatology Hospital

Unknown

Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis

Actinic Keratosis

China
Shenzhen People's Hospital

Unknown

Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer (BINC-B)

Breast Neoplasms

China
Fuda Cancer Hospital, Guangzhou

Completed

Safety and Efficacy Study of Mix Vaccine in Breast Carcinoma Patient

Breast Neoplasms

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study of IBI363 in Subjects With Advanced Melanoma

Melanoma

China
Shanghai Kechow Pharma, Inc.

Recruiting

Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

Melanoma

China
Shanghai Escugen Biotechnology Co., Ltd

Not yet recruiting

A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Metastatic Breast Cancer

China
Wenjin Yin

Recruiting

Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer

Advanced Breast Cancer

China
RenJi Hospital

Recruiting

RC48-ADC in HER2-low Advanced Breast Cancer

Advanced Breast Cancer

China
Peking University

Not yet recruiting

Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer

Invasive Breast Cancer

China
Amgen

Completed

A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants

Atopic Dermatitis

China
Fudan University

Active, not recruiting

Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

Metastatic Breast Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer

Metastatic Breast Cancer

China
Taizhou EOC Pharma Co., Ltd.

Completed

Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer

Solid Tumor, Adult

China
Fudan University
Chinese Anti-Cancer Association

Completed

Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy

Primary Breast Cancer

China
Peking University

Completed

Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure (CTREP)

Invasive Breast Cancer

China
Peking Union Medical College

Unknown

Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

Breast Neoplasm Female | Mutation | Therapeutics

China
Fudan University

Unknown

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

Early Breast Cancer

China
Peking Union Medical College

Unknown

Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

Breast Cancer | HER2 Gene Mutation

China
Fudan University

Terminated

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer

China
Tao OUYANG

Completed

A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes

Metastatic Breast Cancer

China
Peking Union Medical College Hospital

Unknown

Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer (AETNBC)

Female Breast Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Qilu Pharmaceutical Co., Ltd.

Unknown

A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer

Advanced Breast Cancer

China
Nanjing First Hospital, Nanjing Medical University

Recruiting

Clinical Observation of Exosomes in Patients After Q-switched Laser Surgery

Laser | Exosome | Skin Regeneration

China
Shanghai Zhongshan Hospital

Recruiting

A Pilot Study in Severe Patients With Takayasu Arteritis.

Takayasu Arteritis | Treatment | Tocilizumab | Adalimumab

China
Shanghai Yueyang Integrated Medicine Hospital

Not yet recruiting

The Relationship Between Moderate-to-severe Psoriasis and Sleep Disturbance

Moderate-to-severe Psoriasis

China
Beijing Institute of Heart, Lung and Blood Vessel...
Peking University People's Hospital; Shanghai Zhongshan Hospital

Recruiting

A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)

Takayasu's Arteritis

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Breast Neoplasms

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer

Breast Neoplasms

China
wang shusen

Recruiting

Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy (SMA-BC-002)

Breast Neoplasms

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line to Third-line Treatment for HER2-positive Metastatic Breast Cancer

Breast Neoplasms

China
Zhejiang Cancer Hospital
Pfizer

Recruiting

Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese Patients

Breast Neoplasms

China
Lee's Pharmaceutical Limited

Completed

Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne

Acne

China
Organisation for Oncology and Translational Research

Unknown

Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

Breast Neoplasms

China

3

Subscribe